The Schirmer Tear Test is a cornerstone in modern ophthalmology and optometry for assessing tear production. Whether you are a clinician refining your diagnostic toolkit or a patient seeking to understand what your test results mean, this guide offers clear explanations, practical tips, and evidence-informed context. We explore the Schirmer Tear Test in detail, including its variations, interpretation, limitations, and how it fits within a broader dry eye assessment.
Schirmer Tear Test: What It Is and Why It Matters
The Schirmer Tear Test, sometimes written as Schirmer test or Schirmer’s test, is a simple, pencil-sized strip of filter paper placed inside the lower eyelid to measure tear production. In clinical practice, the test provides a quantitative estimate of tear volume over a fixed period, typically five minutes. When used correctly, Schirmer Tear Test results contribute to differentiating between aqueous-deficient dry eye and evaporative forms, guiding treatment plans and monitoring responses to therapy.
Schirmer Tear Test and Its Variants
There are two main variants of the Schirmer Tear Test commonly employed in clinics:
- Schirmer I test (without anaesthetic): Measures both basal and reflex tear secretion. It can be influenced by environmental factors, patient anxiety, and reflex tearing from irritation.
- Schirmer II test (with topical anaesthetic): Measures basal tear production by suppressing reflex tearing. This variant is particularly useful when clinicians want to focus on gland function independent of ocular surface stimulation.
In clinical notes and literature you may also encounter references to Schirmer II as a test that assesses basal secretion, and Schirmer I as the combined basal and reflex component. The terminology can vary slightly by region or institution, but the practical distinction remains whether anaesthetic is used and what portion of tear production is being measured.
Historical Perspective: How the Schirmer Tear Test Evolved
The Schirmer Tear Test has its roots in mid-20th-century ophthalmic practice, arising from efforts to quantify lacrimal function beyond subjective symptom reporting. Early versions relied on paper strips and manual measurement, with refinements over decades to standardise strip size, placement, and observation time. Today’s iterations balance ease of use with reliability, becoming a routine part of dry eye workups in many eye clinics across the UK and beyond.
The Value of Standardisation
Standardising procedure is essential because tear production fluctuates with time of day, ambient humidity, and systemic factors. By adhering to consistent strip dimensions, placement, and timing, clinicians can compare results over time and across patients with greater confidence. This is particularly important when diagnosing conditions such as keratoconjunctivitis sicca or Sjögren’s syndrome, where tear production measurement complements other diagnostic tests.
Indications for the Schirmer Tear Test in Everyday Practice
Schirmer Tear Test remains a practical first-line tool in several scenarios:
- Evaluation of persistent dry eye symptoms, such as a gritty sensation, burning, or intermittent blurred vision.
- Pre-operative assessment for refractive surgery where tear film stability can influence outcomes.
- Monitoring of patients on medications known to affect tear production (for example, antihistamines, antidepressants, or topical preservatives).
- Assessment of suspected aqueous-deficient dry eye in patients with autoimmune conditions, including features suggestive of Sjögren’s syndrome.
- Measuring tear production before and after therapeutic interventions such as artificial tears or anti-inflammatory regimens.
Schirmer Tear Test Procedure: Step-by-Step Basics
Implementing the Schirmer Tear Test correctly is crucial for obtaining meaningful results. While local protocols may vary slightly, the core steps are broadly similar across clinics.
Materials You’ll Need
- Standard Schirmer strips (Whatman filter paper No. 41 or equivalent).
- Clean gloves and standard infection-control supplies.
- Topical anaesthetic drops if performing Schirmer II (as prescribed by protocol).
- Clean clock or timer to measure the five-minute interval accurately.
Preparation and Positioning
Explain the procedure to the patient to obtain informed consent and ensure comfort. Have the patient lean back slightly and look straight ahead. Avoid placing the strip in the central cornea area to minimise irritation and reflex tearing from contact with the eye’s surface.
Placement and Timing
- For Schirmer I (without anaesthetic): Place the folded end of the strip into the lower conjunctival fornix, about one millimetre from the lid margin. Ensure the strip lies flat and does not touch the cornea.
- For Schirmer II (with anaesthetic): After applying topical anaesthetic to the conjunctival surface and waiting the recommended onset time, place the strip as described for Schirmer I, then begin timing.
- Close the eyelids gently or keep them partially closed for the full five minutes, depending on clinic preference and patient comfort.
Reading the Results
At the end of five minutes, lift the strip carefully and measure the length of the moistened area in millimetres. Record the measurement to the nearest millimetre. The interpretation is based on established thresholds, with higher values indicating greater tear production and lower values suggesting hyposecretion.
Interpreting Schirmer Tear Test Results: What Do the Numbers Mean?
Interpreting Schirmer Tear Test results requires context. Normal tear production ranges can vary with age, environment, and testing method. Here are commonly used guidelines, noting that local practice may adopt slightly different cut-offs:
- Schirmer I (without anaesthetic): Wetting of >15 mm in five minutes is generally considered normal. About 10–15 mm may indicate mild aqueous deficiency or borderline tear production. < 5–10 mm often suggests moderate to severe dry eye, particularly when accompanied by symptoms or other ocular surface signs.
- Schirmer II (with anaesthetic): Normal basal tear production is typically higher than 10–15 mm in five minutes, though exact thresholds vary. Values <5–10 mm may indicate reduced basal tear secretion, which can occur in certain lacrimal gland disorders or inflammatory states.
Interpreting results in isolation has limitations. Clinicians integrate Schirmer Tear Test findings with symptom reports, objective measures (such as tear break-up time, ocular surface staining), and patient history to reach a comprehensive diagnosis. In conditions like Sjögren’s syndrome, a low Schirmer Tear Test value supports, but does not confirm, the diagnosis, which relies on a combination of criteria including serology and salivary gland assessment.
Limitations and Common Pitfalls of the Schirmer Tear Test
No diagnostic test is perfect, and the Schirmer Tear Test has well-recognised limitations that clinicians should acknowledge:
- Variability: Tear production can vary by time of day, environmental humidity, and recent use of eye drops or systemic medications.
- Reflex tearing: In Schirmer I, the sight or irritation of the strip can induce reflex tearing, potentially inflating the measurement and underestimating true basal secretion.
- Technique sensitivity: Strip placement, distance from the lid margin, and whether the strip remains in contact with the conjunctival surface affect results.
- Psychological and comfort factors: Patient anxiety or discomfort can increase blinking and tearing, confounding the reading.
- Standardisation challenges: Across clinics, differences in strip brand, thickness, and reading conventions can introduce variability.
Schirmer Tear Test: Practical Tips for Clinicians
To maximise reliability and repeatability of the Schirmer Tear Test, consider the following practical tips:
- Adhere to uniform strip size and placement conventions; document the exact strip type used and the measurement method in the patient record.
- Control environmental conditions where possible; a dry room or air-conditioned environment can influence tear evaporation and tear production dynamics.
- For serial measurements, ensure consistent timing relative to the patient’s daily routine and medications to reduce variability.
- When using Schirmer I, note whether the reading reflects basal plus reflex tears; interpret accordingly in the context of the patient’s symptoms.
- Incorporate complementary tests such as tear film osmolarity, TBUT (tear break-up time), and ocular surface staining to build a robust clinical picture.
Schirmer Tear Test Versus Other Dry Eye Tests: How They Work Together
The Schirmer Tear Test is one component of a broader dry eye evaluation. Other tests play important roles in characterising the condition and guiding management:
- Tear Break-Up Time (TBUT): Assesses tear film stability by measuring the time until the first dry spot appears on the cornea after a blink. Short TBUT indicates instability and evaporative dry eye.
- Aqueous Tear Osmolarity: Determines tear solute concentration, with higher osmolarity suggesting tear film hyperosmolarity associated with dry eye disease.
- Ocular Surface Staining: Uses dyes such as fluorescein, lissamine green, or rose bengal to reveal areas of epithelial damage and dry eye severity.
- Meibomian Gland Assessment: Evaluates gland function and secretions, important for identifying evaporative forms related to meibomian gland dysfunction.
- Tonometry and Vision Testing: While not diagnostic for dry eye, these assessments help evaluate the broader impact on visual function and ocular health.
Clinical Applications: From Everyday Practice to Special Situations
The Schirmer Tear Test informs a wide range of clinical decisions. Here are some common scenarios in which its results may influence care:
- Chronic dry eye management: Adjusting artificial tears, lubricants, or anti-inflammatory therapies based on tear production trends.
- Autoimmune screening: In patients with suspected Sjögren’s syndrome, abnormal Schirmer Test results contribute to diagnostic workups alongside serological tests and imaging.
- Pre-surgical evaluation: Ensuring adequate tear production and ocular surface health before cataract or refractive surgery to optimise healing and outcomes.
- Contact lens tolerance: Poor tear production may predict difficulties with contact lens wear; management may include lubricant drops or alternative lens strategies.
Special Populations: Tailoring the Schirmer Tear Test
Different patient groups may require minor adjustments in approach or interpretation:
- Children and adolescents: Cooperation and comfort are crucial. Shorter testing times and patient-friendly explanations help obtain reliable measurements.
- Older adults: Age-related changes in tear production and corneal sensitivity can influence results; consider comprehensive assessment in conjunction with systemic health factors.
- Post-surgical patients: Early post-operative periods may show transient fluctuations in tear production; serial testing aids in monitoring recovery.
Interpreting Schirmer Tear Test in Combination with Symptoms
While objective measurements are important, pairing Schirmer Tear Test results with patient-reported symptoms provides a more holistic view. For instance, a moderately reduced Schirmer score in a patient reporting constant grittiness and intermittent blurred vision is clinically meaningful and warrants a targeted therapeutic plan. Conversely, a low score with minimal symptoms may prompt monitoring and lifestyle adjustments, while a high score does not always guarantee symptom relief, highlighting the complex nature of ocular surface disease.
Practical Considerations for Home and Self-care
For patients who organise home eyedrops or lifestyle changes to manage dry eye, understanding the role of tear production helps in setting realistic expectations. While the Schirmer Tear Test requires a clinical setting, maintaining a consistent daily routine can support tear film stability. Hydration, humidified environments, regular blinking during screen use, and adherence to prescribed lubricants or anti-inflammatory therapies can improve symptoms and tear quality over time.
Future Directions: Advances in Tear Assessment
Ophthalmology continues to evolve with innovations in tear film analysis. Emerging techniques aim to offer more precise assessments of tear production, composition, and ocular surface health. Combination workflows that integrate Schirmer Tear Test data with advanced imaging, tear proteomics, and real-world symptom tracking hold promise for personalised dry eye management. Clinicians may increasingly combine traditional Schirmer results with novel biomarkers to refine diagnoses and tailor therapies more effectively.
Conclusion: The Schirmer Tear Test as a Practical Diagnostic Tool
In routine eye care, the Schirmer Tear Test remains a practical, widely available method for quantifying tear production. Used thoughtfully—acknowledging its limitations and interpreting results alongside symptoms and other tests—it supports clinicians in diagnosing, monitoring, and treating dry eye disease. Whether employing Schirmer I or Schirmer II, the essential goal is to understand the tear film’s health and to guide patients toward comfort and clearer vision. By integrating this test into a comprehensive assessment, clinicians can deliver targeted care that addresses both the surface of the eye and the underlying lacrimal function that sustains it.
